Band-like sensory disturbance around the trunk is characteristic of which myelopathy, and if non‑compressive what is the usual cause?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Band-Like Sensation in Myelopathy

A band-like sensory disturbance around the trunk is characteristic of thoracic myelopathy, and when non-compressive, the most common causes are demyelinating diseases (particularly multiple sclerosis), spinal cord ischemia, or metabolic myelopathies such as vitamin B12 deficiency. 1, 2

Anatomical Localization

  • Band-like sensations (also called sensory levels) typically indicate thoracic spinal cord pathology, as the dermatomal distribution creates a circumferential pattern around the trunk 3
  • The sensory level corresponds to the highest level of spinal cord dysfunction, though false localizing sensory levels can occur 4
  • Cervical myelopathy can paradoxically present with thoracic sensory levels (T4-T10), creating diagnostic confusion and potentially delaying appropriate treatment 4

Critical Pitfall

  • Do not assume a thoracic sensory level always indicates thoracic cord pathology - cervical compression can produce false localizing thoracic sensory levels in up to 4 documented cases, with persistence of these levels even after successful cervical decompression surgery 4
  • Always image the cervical spine with MRI even when clinical examination suggests a thoracic level 4

Non-Compressive Causes

Demyelinating Disease (Most Common Non-Compressive Etiology)

  • Multiple sclerosis involves the spinal cord in 80-90% of patients, most commonly affecting the cervical cord, though thoracic involvement produces the classic band-like sensation 1, 2
  • MS spinal cord lesions are typically small (≤2 vertebral segments), peripherally located in lateral and posterior columns, and wedge-shaped on axial imaging 5
  • Neuromyelitis optica (NMO) causes longitudinally extensive transverse myelitis (≥3 vertebral segments) with cloud-like enhancement patterns, distinguishing it from MS 5, 2

Vascular Causes

  • Spinal cord ischemia results from atheromatous disease, aortic surgery complications, systemic hypotension, or fibrocartilaginous embolic disease 2
  • Spinal arteriovenous malformations cause progressive myelopathy through venous hypertension, with characteristic dorsal cord edema and enlarged veins 1, 2

Metabolic Causes

  • Vitamin B12 deficiency produces subacute combined degeneration with characteristic posterior and lateral column involvement 1, 2, 3
  • Copper deficiency myelopathy presents similarly to B12 deficiency 2, 3

Infectious Causes

  • Human T-cell lymphotropic virus myelitis, tuberculosis, HIV vacuolar myelopathy, and schistosomiasis can all produce non-compressive myelopathy with band-like sensations 1, 2, 3

Diagnostic Approach

  • MRI without and with IV contrast is essential to distinguish compressive from non-compressive etiologies and evaluate for inflammatory, infectious, or neoplastic causes 1, 3
  • Contrast enhancement patterns help differentiate etiologies: pancake-like enhancement suggests spondylotic myelopathy 5, 6, cloud-like enhancement suggests NMO 5, and band-like enhancement suggests Balo concentric sclerosis 5
  • Diffusion-weighted imaging should be included when spinal cord ischemia is suspected, as it shows signal changes earlier than T2-weighted sequences 1

Imaging Characteristics by Etiology

  • MS lesions: Small, focal, peripherally located, wedge-shaped on axial views 5
  • NMO lesions: Longitudinally extensive (≥3 segments), central gray matter involvement, cloud-like enhancement 5
  • Metabolic myelopathy: Posterior and lateral column T2 hyperintensity without enhancement 1
  • Ischemic myelopathy: Central gray matter involvement (owl's eyes sign), restricted diffusion 1

References

Guideline

acr appropriateness criteria® myelopathy: 2021 update.

Journal of the American College of Radiology, 2021

Guideline

Causes and Clinical Context of Myelopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Myelopathy Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

In an 86‑year‑old woman with several days of right‑sided head and facial paresthesias, right neck and arm pain, a normal brain MRI, and cervical MRI showing multilevel spondylosis with severe central canal stenosis and cord compression at C4‑5 (moderate cord deformity at C5‑6), what laboratory studies and additional diagnostic tests should be obtained?
Can multiple falls cause cervical spondylosis and myelopathy?
What are the symptoms of cervical arthritis (cervical spondylosis)?
When is an MRI with contrast versus without contrast indicated for suspected nerve damage in the cervical spine?
What is the significance of straightening of the cervical spine, indicating myospasm, and mild spondyloarthritic (spondyloarthritis) changes?
What are suitable alternative antihypertensive options to Atasart 16 mg (candesartan cilexetil) for maintenance therapy?
What are the major complications of ascites and how should they be managed?
In a pregnant woman with a singleton gestation, when and how should first‑trimester screening for aneuploidy be offered, and what follow‑up steps are recommended if the calculated risk is elevated?
What is the recommended denosumab (Xgeva) dosing schedule for severe or refractory hypercalcemia (e.g., malignancy‑related or when bisphosphonates are contraindicated due to renal insufficiency), how should calcium, phosphate, creatinine and vitamin D be monitored, and what are the alternative therapies if denosumab cannot be used?
How should metabolic acidosis be managed in an intubated adult ICU patient with ventilator‑associated pneumonia, a growing pleural effusion, and new tachypnea?
How should tyrosine‑kinase inhibitors be managed in patients with impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.